A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome
Open Access
- 17 October 2017
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 93 (2), 510-518
- https://doi.org/10.1016/j.kint.2017.08.011
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literaturePediatric Nephrology, 2011
- Long-term effects of levamisole treatment in childhood nephrotic syndromePediatric Nephrology, 2004
- Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in ratsJournal of Pharmacy and Pharmacology, 2004
- Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise?Pediatric Nephrology, 2004
- The use of steroid-sparing agents in steroid-sensitive nephrotic syndromePediatric Nephrology, 2003
- Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problemsStatistics in Medicine, 2002
- Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UKPediatric Nephrology, 2001
- Steroid responsive nephrotic syndrome is more common in Asians.Archives of Disease in Childhood, 1985
- The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone: A report of the international study of kidney disease in childrenThe Journal of Pediatrics, 1981